Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Birth Control Methods01:22

Birth Control Methods

337
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although...
337
Natural Selection and Mating Preferences01:06

Natural Selection and Mating Preferences

133
The principle of natural selection posits that organisms better adapted to their environment are more likely to survive and reproduce. This principle is closely intertwined with mating preferences, a key aspect of sexual selection, which evolutionary psychologists believe is driven by instincts to propagate one's genes. Such instincts significantly influence mating behaviors and preferences between genders.
Females, due to their biological roles in conception, pregnancy, and nursing,...
133
Adrenergic Antagonists: ɑ and β-Receptor Blockers01:31

Adrenergic Antagonists: ɑ and β-Receptor Blockers

511
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
511
Preclinical Development: Overview01:28

Preclinical Development: Overview

4.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.5K
Infertility in Females01:28

Infertility in Females

348
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
348
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics01:11

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics

478
All neuromuscular blocking agents are injected intravenously because they are poorly absorbed from the GI tract. Rapid onset is achieved with intravenous administration, although absorption is also adequate from an intramuscular injection. Since these agents are highly ionized, they do not readily penetrate cell membranes or cross the blood-brain barrier.
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
478

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction to: Induction of CNS α-synuclein pathology by fibrillar and non-amyloidogenic recombinant α-synuclein.

Acta neuropathologica communications·2026
Same author

The mannosyltransferase DPM1 regulates the activity of ER-stress sensor IRE1 in colorectal cancer.

Nature communications·2026
Same author

Genome annotation of <i>Microbacterium</i> phage Statler containing a putative anti-CBASS gene (Acb2).

Microbiology resource announcements·2026
Same author

Canonical and variant PRC1 functionally converge on PRC2 targets to regulate transcriptional programs during mouse limb development.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Changes in the provision of hospital-based second-trimester uterine evacuation post-Dobbs in a consistently abortion-restrictive state.

Contraception·2026
Same author

Factors Associated with Nonadherence to American College of Obstetricians and Gynecologists Guidelines for Labor Arrest Disorders.

American journal of perinatology·2026

Related Experiment Video

Updated: Jul 19, 2025

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
09:34

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

9.0K

Women's preferences for a new contraceptive under development: an exploratory study.

Tessa Madden1, Sarah Y Cohen1, Rachel Paul1

  • 1Divisions of Family Planning & Clinical Research, Department of Obstetrics and Gynecology, Washington University in St. Louis School of Medicine, St. Louis, MO, United States.

Frontiers in Global Women'S Health
|August 7, 2023
PubMed
Summary

New on-demand, non-hormonal female contraceptives are of interest to users. Preferences include small size, low cost, and discreet use, informing future product development for unmet contraceptive needs.

Keywords:
MTurkcontraceptioncontraceptive developmentcontraceptive preferencesnonhormonal

More Related Videos

Contractility Measurements of Human Uterine Smooth Muscle to Aid Drug Development
07:56

Contractility Measurements of Human Uterine Smooth Muscle to Aid Drug Development

Published on: January 26, 2018

16.6K
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
00:04

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.7K

Related Experiment Videos

Last Updated: Jul 19, 2025

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
09:34

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

9.0K
Contractility Measurements of Human Uterine Smooth Muscle to Aid Drug Development
07:56

Contractility Measurements of Human Uterine Smooth Muscle to Aid Drug Development

Published on: January 26, 2018

16.6K
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
00:04

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.7K

Area of Science:

  • Reproductive Health
  • Contraceptive Development
  • User Preference Research

Background:

  • Current contraceptive methods do not meet all users' needs.
  • End-user input is often lacking in early contraceptive development.
  • Novel contraceptive options are required to address diverse user preferences.

Purpose of the Study:

  • To explore end-user preferences for a novel on-demand, non-hormonal female contraceptive.
  • To gather input on desired attributes and potential concerns for a new contraceptive method.
  • To inform the development process of a new female contraceptive.

Main Methods:

  • An exploratory web-based survey was conducted using Amazon Mechanical Turk (MTurk).
  • Eligible participants were cis-gender females aged 18-44 who previously used barrier contraception.
  • Survey included demographic information, reproductive history, contraceptive description, interest levels, and attribute preferences.

Main Results:

  • 73.8% of 500 respondents expressed interest in the on-demand, non-hormonal contraceptive.
  • Preferred attributes: small size (≤2 inches), rod-shaped, low cost (<$5/use), and discreet application.
  • Key concerns included vaginal irritation (51.6%) and effectiveness (46.4%); 60% were confident in correct use.

Conclusions:

  • Significant end-user interest exists for the novel contraceptive concept.
  • User-defined preferences for size, cost, and discreetness should guide further development.
  • Incorporating end-user feedback is crucial for creating acceptable and effective contraceptive methods.